BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stachulski AV, Taujanskas J, Pate SL, Rajoli RKR, Aljayyoussi G, Pennington SH, Ward SA, Hong WD, Biagini GA, Owen A, Nixon GL, Leung SC, O'Neill PM. Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? ACS Infect Dis 2021;7:1317-31. [PMID: 33352056 DOI: 10.1021/acsinfecdis.0c00478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Faisthalab R, Suppiah S, Dorsey M, Sullivan KE, Icenogle J, Perelygina L. Drug Sensitivity of Vaccine-Derived Rubella Viruses and Quasispecies Evolution in Granulomatous Lesions of Two Ataxia-Telangiectasia Patients Treated with Nitazoxanide. Pathogens 2022;11:338. [DOI: 10.3390/pathogens11030338] [Reference Citation Analysis]
2 Vicenti I, Martina MG, Boccuto A, De Angelis M, Giavarini G, Dragoni F, Marchi S, Trombetta CM, Crespan E, Maga G, Eydoux C, Decroly E, Montomoli E, Nencioni L, Zazzi M, Radi M. System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. Eur J Med Chem 2021;224:113683. [PMID: 34273661 DOI: 10.1016/j.ejmech.2021.113683] [Reference Citation Analysis]
3 Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232 [PMID: 34876784 DOI: 10.3748/wjg.v27.i42.7210] [Reference Citation Analysis]
4 Ezquerra-Aznárez JM, Almeida da Silva PE, Aínsa JA. Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs. Microorganisms 2021;9:2335. [PMID: 34835459 DOI: 10.3390/microorganisms9112335] [Reference Citation Analysis]
5 Thapa K, Verma N, Singh TG, Kaur Grewal A, Kanojia N, Rani L. COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol 2021;101:108328. [PMID: 34768236 DOI: 10.1016/j.intimp.2021.108328] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Neary M, Arshad U, Tatham L, Pertinez H, Box H, Rajoli RK, Valentijn A, Sharp J, Rannard SP, Biagini GA, Curley P, Owen A. Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. bioRxiv 2021:2021. [PMID: 34075381 DOI: 10.1101/2021.05.27.445500] [Reference Citation Analysis]
7 Wang Z, Yang L. Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges. J Med Virol 2021. [PMID: 34897729 DOI: 10.1002/jmv.27517] [Reference Citation Analysis]
8 Enríquez López KY, Meneses Calderón J, de la Cruz Ávila L, López Esquivel MÁ, Meneses Figueroa J, Vargas Contreras MJ, Anaya Herrera J, Sotelo Martínez OR, Mendoza López JA, Mendieta Zerón H. Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital. Cureus 2021;13:e15002. [PMID: 34131543 DOI: 10.7759/cureus.15002] [Reference Citation Analysis]